Adverse reactions reported in clinical trials in adults and greater than or equal to 2% of WEGOVY-treated patients and more frequently than in placebo-treated patients are shown in Table 3
HIV protease inhibitorsritonavir, indinavir, saquinavir, nelfinavir, and zidovudinewere described as ABCC1 substrate [35], suggesting that the overexpression of ABCC1 in infected cells makes these cells more resistant to chemotherapy
This supplement is also enhanced with N-acetyl-cysteine (NAC), which is an essential amino acid that supports glutathione synthesis
Currently, AD patients with positive tau pathology exhibit poor responsiveness to anti-A antibody treatments, which are ineffective in reducing tau levels [106]
This product is not intended to diagnose, treat, cure, or prevent any disease